- Home
- News e Eventi
- Eventi e congressi internazionali
- Hemostasis Science Weeks

Hemostasis Science Weeks Connecting experts around the world and across healthcare specialties
Join us March 4–April 1, 2021
Hemostasis Science Weeks event is a free, online scientific series that helps connect lab and clinical experts around the world. In this forum, leading independent hemostasis experts share scientific insights into current clinical practice, what’s new, and what’s coming in hemostasis testing.
Please use Google Chrome or Firefox to both register and join the event. Internet Explorer is not recommended.
You're invited!
Watch this video to learn what you can expect during the Hemostasis Science Weeks.
Chairman Prof. Dr. Ulrich Sachs, Head of the Department of Thrombosis and Hemostasis at the Giessen and Marburg University Hospital in Giessen, Germany, invites you to join him and our hemostasis experts for this event.
Please use Google Chrome or Firefox to both register and join the event. Internet Explorer is not recommended.
Register here to:
- Join scientific live sessions with renowned experts.
- Engage in live Q&A.
- Attend sessions that are relevant for your practice.
- Create a personalized agenda according to your interests and schedule.
- Receive a personalized certificate of participation.
- Watch session replays on demand.
Choose your sessions!
Lab professionalsHemostaseologistsAnesthesiologistsCardiologistsGynecologistsPhysiciansAgenda
Join renowned speakers in five sessions to gain insights into the latest developments in hemostasis testing and the management of coagulation disorders.
Chairman: Prof. Dr. Ulrich Sachs

Session 1:
COVID-19–associated Coagulopathy
COVID-19–associated Coagulopathy
March 4, 2021 | 3:00–6:00 p.m. CET
Join this session to learn about the impact of COVID-19 on hemostasis and the pathophysiology of associated coagulopathy. Learn more about recommended laboratory testing and patient management of coagulation in COVID-19.
View full session details.
Title
Speaker
Time (CET)
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, Germany3:00–3:05 p.m.
Strong Impact on Hemostasis
in COVID-19 PatientsProf. Dr. Sophie Susen
Lille, France3:05–3:45 p.m.
Laboratory Testing in COVID-19
–associated CoagulopathyDr. Jecko Thachil
Manchester, United Kingdom3:45–4:25 p.m.
Break
4:25–4:40 p.m.
Immunothrombosis in COVID-19–
associated CoagulopathyDr. Leo Johannes Nicolai
Munich, Germany4:40–5:20 p.m.
Managing COVID-19–associated
CoagulopathyProf. Dr. Alex Spyropoulos
New York, USA5:20–6:00 p.m.

Session 2:
Managing the Bleeding Patient
Managing the Bleeding Patient
March 11, 2021 | 3:00–6:00 p.m. CET
In this session, experts discuss improvements in hemophilia patient management in recent years. Join this session to learn how they not only affect treatment but also the laboratory.
View full session details.
Title
Speaker
Time (CET)
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, Germany3:00–3:05 p.m.
Extended Half-life Coagulation
Factors for Hemophilia Therapy:
Clinically Advantageous, Challenging
for the LaboratoryDr. Stefan Tiefenbacher
Englewood, USA3:05–3:45 p.m.
Emicizumab for Routine Prophylaxis
in Hemophilia A: Clinical and
Laboratory ExperiencePD Dr. Jens Müller
Bonn, Germany3:45–4:25 p.m.
Break
4:25–4:40 p.m.
Hemostasis Derangement during
Mechanical Circulatory SupportPD Dr. Dr. Ingvild Birschmann
Bad Oeynhausen, Germany4:40–5:20 p.m.
Biology Network Modeling:
New Targets in Hemophilia TherapyProf. Dr. Víctor Jiménez-Yuste
Madrid, Spain5:20–6:00 p.m.

Session 3:
Hemostasis Testing in Cardiac and Vascular Disease
Hemostasis Testing in Cardiac and Vascular Disease
March 18, 2021 | 3:00–6:00 p.m. CET
Prevention of acute thrombosis using anticoagulants is the primary strategy in patients suffering from cardiovascular disease. This session gives insights on laboratory parameters that are key in patient and therapy management.
View full session details.
Title
Speaker
Time (CET)
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, Germany3:00–3:05 p.m.
Testing for Direct Oral Anticoagulants
(DOACs): When and HowProf. Dr. Hugo ten Cate
Maastricht, the Netherlands3:05–3:45 p.m.
Drug Levels, Bleeding, and Thrombotic
Outcomes in Patients under Direct
Oral AnticoagulantsDr. Sophie Testa
Cremona, Italy3:45–4:25 p.m.
Break
4:25–4:40 p.m.
The Utility of D-dimer and F1+2
in Cardiovascular Disease and
Anticoagulation ManagementAssoc. Prof. Dr. Christina Christersson
Uppsala, Sweden4:40–5:20 p.m.
Real-time Monitoring of von Willebrand
Factor in the Catheterization Laboratory:
The Seatbelt of Mini-invasive Transcatheter
Aortic Valve ReplacementDr. Flavien Vincent
Lille, France5:20–6:00 p.m.

Session 4:
Hemostasis Management in Pregnancy and Obstetrics
Hemostasis Management in Pregnancy and Obstetrics
March 25, 2021 | 3:00–5:05 p.m. CET
This session focuses on thrombotic events occurring in pregnancy. Hear more about recommendations for managing women at risk of thrombosis or DIC in clinical practice.
View full session details.
Title
Speaker
Time (CET)
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, Germany3:00–3:05 p.m.
Thrombophilia and VTE
in PregnancyProf. Dr. Birgit Linnemann
Regensburg, Germany3:05–3:45 p.m.
Hemostatics Aspects of Peripartum
Hemorrhage and Impact of Factor XIIIProf. Dr. Wolfgang Korte
St. Gallen, Switzerland3:45–4:25 p.m.
Disseminated Intravascular Coagulation
in Pregnancy: Insights in Pathophysiology,
Diagnosis, and ManagementDr. Jecko Thachil
Manchester, United Kingdom4:25–5:05 p.m.

Session 5:
New Insights in Mechanisms and Management of the Hemostatic Balance
New Insights in Mechanisms and Management of the Hemostatic Balance
April 1, 2021 | 3:00–5:05 p.m. CET
In this session, experts discuss new insights into the coagulation process. Learn more about novel factors and mechanisms that can affect thrombosis and bleeding and how they can be managed.
View full session details.
Title
Speaker
Time (CET)
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, Germany3:00–3:05 p.m.
Time to Change the Classical Vision
of Coagulation in Liver Disease: From
Balance Disequilibrium to SystemsDr. Joan C. Reverter
Barcelona, Spain3:05–3:45 p.m.
Coagulation Factor XII in
Thrombosis and InflammationProf. Dr. Dr. Thomas Renné
Hamburg, Germany3:45–4:25 p.m.
Role of Complement Factor H
in HemostasisDr. Meike Heurich-Sevcenco
Cardiff, United Kingdom4:25–5:05 p.m.
Powered by hemostasis experts, presented by Siemens Healthineers
During this time of uncertainty, safety must be our top priority. But we also believe that, especially during the pandemic, staying informed about trends and developments in hemostasis testing is essential. To provide scientific insights flexibly and safely, we will bring this event to you virtually.
As a leader in hemostasis testing, Siemens Healthineers passionately supports hemostasis research and sharing of scientific insights to make them accessible to experts around the world.
#HSW21